Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Bogner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Cancer Research and Clinical Oncology|September 4, 2009
Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 statusAlexander Hoellein, Thomas Decker, Christian Bogner, et al.
Molecular Cell|February 1, 2020
Allosteric Regulation of BH3 Proteins in Bcl-x<sub>L</sub> Complexes Enables Switch-like Activation of BaxChristian Bogner, Justin Kale, Justin Pogmore, et al.
British Journal of Haematology|July 9, 2003
Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cellsChristian Bogner, Ingo Ringshausen, Folker Schneller, et al.
European Radiology|March 31, 2018
Structured reporting adds clinical value in primary CT staging of diffuse large B-cell lymphomaFranziska Schoeppe, Wieland H Sommer, Dominik Nörenberg, et al.
British Journal of Haematology|October 14, 2009
Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expressionChristian Bogner, Tobias Dechow, Ingo Ringshausen, et al.
Haematologica|December 20, 2011
The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletionViola Biberacher, Thomas Decker, Madlen Oelsner, et al.
Blood|October 29, 2015
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemiaMichaela Wagner, Madlen Oelsner, Andrew Moore, et al.
European Radiology|September 10, 2023
Longitudinal MR-based proton-density fat fraction (PDFF) and T2* for the assessment of associations between bone marrow changes and myelotoxic chemotherapyFelix G Gassert, Julia Kranz, Florian T Gassert, et al.
Blood|July 14, 2007
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignanciesIngrid G Schuster, Dirk H Busch, Elfriede Eppinger, et al.
Leukemia & Lymphoma|August 20, 2021
Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signalsSophy Denker, Aitomi Bittner, Mareike Frick, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Cancer Research and Clinical Oncology|September 4, 2009
Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 statusAlexander Hoellein, Thomas Decker, Christian Bogner, et al.
Molecular Cell|February 1, 2020
Allosteric Regulation of BH3 Proteins in Bcl-x<sub>L</sub> Complexes Enables Switch-like Activation of BaxChristian Bogner, Justin Kale, Justin Pogmore, et al.
British Journal of Haematology|July 9, 2003
Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cellsChristian Bogner, Ingo Ringshausen, Folker Schneller, et al.
European Radiology|March 31, 2018
Structured reporting adds clinical value in primary CT staging of diffuse large B-cell lymphomaFranziska Schoeppe, Wieland H Sommer, Dominik Nörenberg, et al.
British Journal of Haematology|October 14, 2009
Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expressionChristian Bogner, Tobias Dechow, Ingo Ringshausen, et al.
Haematologica|December 20, 2011
The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletionViola Biberacher, Thomas Decker, Madlen Oelsner, et al.
Blood|October 29, 2015
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemiaMichaela Wagner, Madlen Oelsner, Andrew Moore, et al.
European Radiology|September 10, 2023
Longitudinal MR-based proton-density fat fraction (PDFF) and T2* for the assessment of associations between bone marrow changes and myelotoxic chemotherapyFelix G Gassert, Julia Kranz, Florian T Gassert, et al.
Blood|July 14, 2007
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignanciesIngrid G Schuster, Dirk H Busch, Elfriede Eppinger, et al.
Leukemia & Lymphoma|August 20, 2021
Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signalsSophy Denker, Aitomi Bittner, Mareike Frick, et al.
Pageof 2